Victoria Sanford
Psychiatric/Mental Health · O Fallon, MONPI 1568013993
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.6% of the total across 796 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 33 manufacturers, the largest accounting for just 13.6% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $4,127, 3.0 times the $1,355 reported in 2021. Among psychiatric/mental health clinicians in MO with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 796 payments — averaging $15.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Neurocrine Biosciences, Inc.$2K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$2K
- Otsuka America Pharmaceutical, Inc.$1K
- Alkermes, Inc.$1K
- AbbVie$1K
- Teva Pharmaceuticals USA, Inc.$847
- plus $4K from 27 others
What the payments were for
- Food & beverage$11,97898%
- Education$3002%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Neurocrine Biosciences, Inc. | 107 | $1,665 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 129 | $1,542 |
| Otsuka America Pharmaceutical, Inc. | 70 | $1,453 |
| Alkermes, Inc. | 88 | $1,420 |
| AbbVie | 99 | $1,381 |
| Teva Pharmaceuticals USA, Inc. | 65 | $847 |
| Axsome Therapeutics, Inc. | 37 | $715 |
| Lundbeck LLC | 30 | $505 |
| E.r. Squibb & Sons, L.L.C. | 20 | $478 |
| Vanda Pharmaceuticals Inc. | 20 | $322 |
| Supernus Pharmaceuticals, Inc. | 19 | $289 |
| Johnson & Johnson | 15 | $278 |
| Sunovion Pharmaceuticals Inc. | 26 | $264 |
| Corium, LLC | 10 | $150 |
| Collegium Pharmaceutical, Inc. | 11 | $149 |
| Sage Therapeutics, LLC | 6 | $120 |
| Exact Sciences | 7 | $115 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $111 |
| Neurelis, Inc. | 4 | $65 |
| Jazz Pharmaceuticals Inc. | 4 | $59 |
| Indivior Inc. | 4 | $53 |
| Noven Therapeutics, LLC | 3 | $49 |
| Ironshore Pharmaceuticals Inc. | 2 | $41 |
| Neos Therapeutics, LP | 2 | $37 |
| Bayer | 2 | $31 |
| Sanofi Pasteur Inc. | 2 | $26 |
| Hologic Sales And Service, LLC | 1 | $18 |
| Lilly USA, LLC | 1 | $18 |
| Mylan Specialty L.p. | 1 | $17 |
| Novo Nordisk | 1 | $16 |
| Kowa Pharmaceuticals America, Inc. | 1 | $16 |
| Sanofi | 1 | $15 |
| Amgen | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LYBALVI$457
- ARISTADA$404
- REXULTI$122
- ABILIFY ASIMTUFII$121
- ABILIFY MAINTENA$121
- VRAYLAR$119
- INGREZZA$119
- Auvelity$116
- ARISTADA INITIO$101
How this compares
$12,279 in reported general payments places this provider in the 95th percentile of 565 psychiatric/mental health providers in Missouri.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| IngrezzaValbenazine Tosylate | 51 | $448,102 |
| AustedoDeutetrabenazine | 27 | $211,258 |
| VraylarCariprazine Hcl | 143 | $210,847 |
| Invega SustennaPaliperidone Palmitate | 55 | $188,531 |
| RexultiBrexpiprazole | 77 | $116,710 |
| Abilify MaintenaAripiprazole | 40 | $114,014 |
| AristadaAripiprazole Lauroxil | 35 | $106,004 |
| FanaptIloperidone | 19 | $65,837 |
| CaplytaLumateperone Tosylate | 35 | $56,106 |
| UzedyRisperidone | 13 | $34,642 |
| VivitrolNaltrexone Microspheres | 15 | $24,660 |
| ZyprexaOlanzapine | 23 | $23,911 |
| TrintellixVortioxetine Hydrobromide | 30 | $22,100 |
| AuvelityDextromethorphan Hbr/Bupropion | 12 | $11,084 |
| Lurasidone Hcl | 79 | $7,393 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Neurocrine Biosciences, Inc.Ingrezza | $1,665 | $448,10251 claims |
| Teva Pharmaceuticals USA, Inc.Austedo, Uzedy | $847 | $245,90040 claims |
| Otsuka America Pharmaceutical, Inc.Rexulti, Abilify Maintena | $1,453 | $230,725117 claims |
| AbbVieVraylar | $1,381 | $210,847143 claims |
| Johnson & JohnsonInvega Sustenna | $278 | $188,53155 claims |
| Alkermes, Inc.Aristada, Vivitrol | $1,420 | $130,66450 claims |
| Vanda Pharmaceuticals Inc.Fanapt | $322 | $65,83719 claims |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta | $1,542 | $56,10635 claims |
| Lilly USA, LLCZyprexa, Olanzapine | $18 | $26,493201 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $111 | $22,10030 claims |
| Axsome Therapeutics, Inc.Auvelity | $715 | $11,08412 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 565 psychiatric/mental health providers in Missouri.
Other psychiatric/mental health in O Fallon
- Aldijana SacicSaint Louis$510K
- Erin DuvallSpringfield$275K
- Laurel OwensLees Summit$246K
- Julie WaterburySaint Louis$135K
- Emily WoukSpringfield$90K
- Kristerpher BrimberryPoplar Bluff$74K
- Matthew LindquistSt Louis$42K
- Stacy EmersonKennett$25K
- Jeffery DavisCreve Coeur$24K
- Kelsey KingsboroughMexico$18K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.